Folic Acid Supplementation and Cardiac and Stroke Mortality among Hemodialysis Patients

The consumption of higher than the standard 1000-μg prescribed dose of folic acid was not beneficial in reducing cardiac or stroke mortality in hemodialysis patients. Similarly, the consumption of less than the standard dose was not associated with an increase in either cardiac or stroke mortality.